As of 2024-12-14, the Relative Valuation of Surmodics Inc (SRDX) is (28.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.99 USD, the upside of Surmodics Inc based on Relative Valuation is -172.2%.
The range of the Relative Valuation is (29.02) - (28.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 41.3x | 38.4x |
| Forward P/E multiples | 30.5x - 35.7x | 33.0x |
| Fair Price | (29.02) - (28.91) | (28.88) |
| Upside | -172.6% - -172.3% | -172.2% |
| Date | P/E |
| 2024-12-12 | -49.44 |
| 2024-12-11 | -49.45 |
| 2024-12-10 | -49.38 |
| 2024-12-09 | -49.61 |
| 2024-12-06 | -49.45 |
| 2024-12-05 | -49.37 |
| 2024-12-04 | -49.34 |
| 2024-12-03 | -48.82 |
| 2024-12-02 | -48.97 |
| 2024-11-29 | -48.77 |
| 2024-11-27 | -48.89 |
| 2024-11-26 | -48.93 |
| 2024-11-25 | -48.91 |
| 2024-11-22 | -48.63 |
| 2024-11-21 | -48.45 |
| 2024-11-20 | -48.43 |
| 2024-11-19 | -48.45 |
| 2024-11-18 | -48.53 |
| 2024-11-15 | -47.87 |
| 2024-11-14 | -47.09 |
| 2024-11-13 | -47.19 |
| 2024-11-12 | -47.67 |
| 2024-11-11 | -47.57 |
| 2024-11-08 | -47.55 |
| 2024-11-07 | -47.48 |
| 2024-11-06 | -47.59 |
| 2024-11-05 | -46.56 |
| 2024-11-04 | -46.45 |
| 2024-11-01 | -46.52 |
| 2024-10-31 | -46.39 |
| 2024-10-30 | -46.36 |
| 2024-10-29 | -46.38 |
| 2024-10-28 | -46.73 |
| 2024-10-25 | -46.47 |
| 2024-10-24 | -47.14 |
| 2024-10-23 | -47.33 |
| 2024-10-22 | -47.33 |
| 2024-10-21 | -47.49 |
| 2024-10-18 | -47.30 |
| 2024-10-17 | -47.45 |
| 2024-10-16 | -47.64 |
| 2024-10-15 | -47.66 |
| 2024-10-14 | -47.38 |
| 2024-10-11 | -47.69 |
| 2024-10-10 | -47.80 |
| 2024-10-09 | -47.66 |
| 2024-10-08 | -47.23 |
| 2024-10-07 | -47.30 |
| 2024-10-04 | -47.50 |
| 2024-10-03 | -47.23 |